Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › Platform for screening NAD+ binding proteins in a cellular context

Platform for screening NAD+ binding proteins in a cellular context

US Patent 12441757 · Granted Oct 14, 2025

Assignee

No assignee recorded.

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

PARP inhibitors for treating cancer and asthma2025
Second generation inhibitors of mitochondrial permeability transition pore with 2025
PARP inhibitors for treating cancer and asthma2024
Compounds and methods used in assessing mono-PARP activity2022
Inhibitors of PARPs that catalyze mono-ADP-ribosylation2021
Biosensors that detect NAD+2019
Kinase inhibitors2016
Selective serine/threonine kinase inhibitors2014
Selective serine/threonine kinase inhibitors2011
Selective serine/threonine kinase inhibitors2010